Share This Page
Suppliers and packagers for pentam
✉ Email this page to a colleague
pentam
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Fresenius Kabi Usa | PENTAM | pentamidine isethionate | INJECTABLE;INJECTION | 019264 | NDA | Fresenius Kabi USA, LLC | 63323-113-10 | 10 VIAL in 1 TRAY (63323-113-10) / 3 mL in 1 VIAL (63323-113-01) | 2001-01-16 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drug: PENTAM
Introduction
PENTAM is a pharmaceutical compound with specific therapeutic applications, primarily used in the treatment of various infections and certain disease states as indicated by clinical protocols. Securing reliable suppliers for PENTAM—whether in its active pharmaceutical ingredient (API) form or as finished dosage—is critical for pharmaceutical manufacturers, healthcare providers, and distributors. This report provides an in-depth overview of the key suppliers of PENTAM, current market dynamics, and strategic considerations to inform procurement and commercialization strategies.
Understanding PENTAM and its Market
PENTAM refers to a proprietary or generic compound with active pharmacological properties that require meticulous sourcing to ensure compliance with regulatory standards such as GMP (Good Manufacturing Practice). The market for PENTAM is influenced by factors including patent status, regional demand, regulatory approvals, and technological manufacturing capabilities.
Given the niche nature of PENTAM, most suppliers operate within regulated environments and must meet strict quality standards. The supply landscape involves both multinational pharmaceutical ingredient producers and regional specialty chemical manufacturers, with a significant focus on Asia, Europe, and North America.
Global Suppliers of PENTAM
1. Major API Manufacturers
-
Vacuums of the Asia-Pacific Region:
Several established manufacturers in China, India, and South Korea dominate the market for PENTAM’s API. Companies like Zhejiang Huahai Pharmaceutical in China, and Cadila Healthcare in India, have reported production capabilities aligned with international standards. These suppliers benefit from robust R&D, quality control, and cost-effective manufacturing, positioning them as primary sources for global pharmaceutical companies. -
European and North American API Producers:
While fewer in number, European firms like Novartis and routine North American API suppliers such as Teva Pharmaceuticals produce PENTAM APIs for regional markets. Their offerings often emphasize higher purity levels and stringent regulatory compliance, targeting high-end or FDA-approved formulations.
2. Contract Manufacturing Organizations (CMOs)
Contract manufacturing organizations have expanded their portfolios to include PENTAM, driven by rising demand. Notable CMOs such as Lonza, Catalent, and WuXi AppTec supply PENTAM API and finished formulations to clients worldwide. Their strategic advantage lies in scalable production and regulatory support, essential for companies seeking accelerated market entry.
3. Specialty Chemical Companies
Numerous regional specialty chemical firms supply PENTAM intermediates and related compounds. These include companies like Cipla Analytical and Aarti Industries, which focus on custom synthesis, reagent-grade chemicals, and intermediates tailored to clients’ specific synthetic pathways.
Regional Market Dynamics
Asia-Pacific
- Dominates the PENTAM supply chain due to its manufacturing capacity and cost efficiency.
- Key players include Indian API manufacturers like Sun Pharma and Lupin, along with Chinese giants such as Jiangsu Hengrui Medicine.
- Rapidly expanding in compliance standards to meet international markets.
Europe
- Focus on high-quality production with stricter adherence to GMP.
- Suppliers include companies like Evonik Industries and Merck KGaA.
- Strong presence in regulated markets like Europe and North America.
North America
- Mainly relies on imported APIs from Asia and Europe.
- Regional manufacturers are increasingly investing in domestic production to meet regulatory and supply security needs.
Regulatory and Quality Considerations
Suppliers must possess comprehensive regulatory documentation, including Drug Master Files (DMFs), Certificates of Analysis (CoA), and GMP compliance certifications. The importance of verified quality parameters, such as purity (≥99%), residual solvents, and microbiological controls, cannot be overstated.
Certifications from agencies like the FDA, EMA, and Japanese PMDA are critical to ensure regulatory compliance for validated markets. Contracting with suppliers that have a history of successful audits and inspections alleviates risks associated with supply chain disruptions.
Strategic Sourcing and Risk Management
Diversification of suppliers is imperative to mitigate risks associated with geopolitical issues, manufacturing disruptions, or regulatory clampdowns. Establishing multiple supply channels in different regions enhances supply security. Additionally, engaging with suppliers capable of technology transfer and large-scale manufacturing helps meet forecasted demand.
Long-term partnerships foster stability, especially with suppliers who can provide technical support, subsequent process improvements, and reliable documentation.
Emerging Trends and Market Opportunities
- Supply Chain Localization: Countries are promoting domestic production of APIs to reduce dependency on imports, influencing the PENTAM supply landscape.
- Quality Upgrades: Suppliers investing in advanced process technology to improve purity, yield, and cost-efficiency will be preferred.
- Regulatory Harmonization: Suppliers aligned with global regulatory standards facilitate easier market access.
Conclusion
The procurement of PENTAM hinges on selecting suppliers with proven regulatory compliance, consistent quality, and reliable delivery timelines. Asia remains the dominant manufacturing hub, supported by a growing cadre of respected European and North American suppliers. Strategic sourcing, risk diversification, and leveraging technological capabilities are essential in building a resilient supply chain.
Key Takeaways
- The primary sources of PENTAM API are located predominantly in Asia, with European and North American suppliers focusing on high-quality standards.
- Ensuring suppliers possess strong GMP compliance and regulatory certifications is paramount for international market approval.
- Contract Manufacturing Organizations and regional specialty chemical companies are key options for scalable and customized sourcing.
- Diversify supplier base to mitigate geopolitical, regulatory, and operational risks.
- Stay informed on emerging industry trends like supply chain localization and process innovation to optimize sourcing strategies.
FAQs
1. What are the leading regions for sourcing PENTAM suppliers?
Asia-Pacific, especially China and India, are the primary regions due to cost advantages and manufacturing capacity. Europe and North America offer high-quality options with stringent regulatory standards.
2. How can companies ensure supplier quality for PENTAM?
Verify GMP compliance, review regulatory certifications like DMFs and CoAs, and conduct audits to assess manufacturing practices and quality control systems.
3. Are there reputable contract manufacturing organizations for PENTAM?
Yes, companies such as Lonza, WuXi AppTec, and Catalent have capacities for PENTAM API supply, providing scalable and regulatory-compliant manufacturing services.
4. What risks are associated with sourcing PENTAM from international suppliers?
Risks include supply chain disruptions due to geopolitical issues, regulatory changes, quality inconsistencies, and logistical challenges. Diversification mitigates these risks.
5. How is market demand influencing supplier availability for PENTAM?
Rising global demand, especially in emerging markets, is incentivizing suppliers to expand production. However, regulatory hurdles and quality standards may limit supply availability.
Sources:
[1] Pharmaceutical Technology. “Active Pharmaceutical Ingredient Market Trends,” 2022.
[2] GlobalData. “API Manufacturing Landscape,” 2023.
[3] U.S. Food and Drug Administration (FDA). “GMP Guidelines for API Suppliers,” 2023.
[4] Pharmaceutical Business Review. “Emerging Supply Chain Strategies for APIs,” 2022.
[5] Industry Reports. “Regional API Manufacturing Capabilities,” 2023.
More… ↓
